Robert Roe looks at regulatory and technological changes that are changing the way drug development is carried out.
“One thing that Anderson says could be very useful in overcoming the challenges in maintaining control of data in the face of an increasingly outsourced business model, is data exchange. ‘Data access points can be limited, just based on the nature of the data that is being acquired, the effort to summarise that data, the ability to take those summaries and interpret the data to make effective decisions.'”